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Membrane damageScolopendin 2 is a 16-mer peptide (AGLQFPVGRIGRLLRK) derived from the centipede Scolopendra subspinipes
mutilans. We observed that this peptide exhibited antimicrobial activity in a salt-dependent manner against var-
ious fungal and bacterial pathogens and showed no hemolytic effect in the range of 1.6 μM to 100 μM. Circular
dichroism analysis showed that the peptide has an α-helical properties. Furthermore, we determined the
mechanism(s) of action using ﬂow cytometry and by investigating the release of intracellular potassium. The re-
sults showed that the peptide permeabilized the membranes of Escherichia coli O157 and Candida albicans,
resulting in loss of intracellular potassium ions. Additionally, bis-(1,3-dibutylbarbituric acid) trimethine oxonol
and 3,3′-dipropylthiacarbocyanine iodide assays showed that the peptide caused membrane depolarization.
Using giant unilamellar vesicles encapsulating calcein and large unilamellar vesicles containing ﬂuorescein
isothiocyanate-dextran, which were similar in composition to typical E. coli O157 and C. albicans membranes,
we demonstrated that scolopendin 2 disrupts membranes, resulting in a pore size between 4.8 nm and 5.0 nm.
Thus, we have demonstrated that a cationic antimicrobial peptide, scolopendin 2, exerts its broad-spectrum an-
timicrobial effects by forming pores in the cell membrane.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Microbial resistance to antibiotics has increased in recent years,
resulting in the invalidation ofmajor antimicrobial drugs used in clinical
settings [1]. Resistance to various antibioticsmay be due to failure of the
drug to interact with its target, efﬂux of the antibiotic from the cell, or
direct destruction or modiﬁcation of the drug [2,3]. The discovery of
novel, broad-spectrum antibiotics with rapid antimicrobial effects and
the ability to limit the induction of microbial resistance may not keep
up with the pace at which pathogens are developing resistance [4,5]..mutilansAssembledEST;ATCC,
n for Type Cultures; MIC,mini-
saline; CD, circular dichroism;
bis-(1,3-dibutylbarbituric acid)
e iodide;GUV, giantunilamellar
ycerol;PC,phosphatidylcholine;
82 53 955 5522.
should be considered co-ﬁrstOne way to overcome the problem of antibiotic resistance is to use
antimicrobial peptides (AMPs), which can be isolated from natural
sources and are effective against a broad range of microorganisms, in-
cluding Gram-positive and Gram-negative bacteria, fungi, and viruses
[4]. AMPs play a signiﬁcant role in the defense systems of higher organ-
isms such as plants, insects, arthropods, amphibians, and mammals [6].
Cell viability ismaintained by preserving the structure of the cell wall or
cytoplasmic membrane, regardless of DNA/protein inhibition by single
or dual mechanism(s). While their antimicrobial properties have only
recently been identiﬁed, AMPs have received attention as novel chemo-
therapeutics, intracellular signaling molecules, and antitumor agents
[5].
AMPs from venom, such as melittin from bees and hadrurin from
scorpions, have been reported previously [6,7]. Centipedes are venom-
ous arthropods that have been used in traditional medicine to treat sev-
eral ailments, including carbuncles and neoplasms [8]. Extracts from
centipedes have been reported to contain antibacterial components
and toxins with anticoagulant properties [6]. In a previous study, we
identiﬁed an antimicrobial peptide, scolopendin 1, from the centipede
Scolopendra subspinipes mutilans [9]. Other antimicrobial peptides from
this species, such as scolopin 1 and 2 and FXa-inhibiting peptide, have
also been reported [9–11]. In this study, we identiﬁed an antimicrobial
peptide from S. s. mutilans and investigated its antimicrobial properties.
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2.1. Transcriptome sequencing
Centipedes were injected with exponential-phase Escherichia coli
(2 × 106 colony forming units (CFU)/centipede). Eighteen hours later,
total RNA was isolated from the centipedes using the RNeasy Total RNA
Isolation Kit (Qiagen, USA). The integrity of RNA was veriﬁed using an
Agilent 2100 Bioanalyzer. Poly(A) mRNA was isolated using oligo(dT)
beads. Short mRNA fragments were obtained by adding fragmentation
buffer, and ﬁrst- and second-strand cDNAwas synthesized in succession.
Short fragments were puriﬁed using the QIAquick PCR Puriﬁcation Kit,
end repair was performed, and a poly(A) tail adapter sequence was
added. Suitable ampliﬁed fragments were selected as templates using
the agarose gel electrophoresis method. Finally, the library was se-
quenced on an Illumina HiSeq™ 2000 System by generating paired-
end libraries with an average insert size of 200 bp, following the
manufacturer's instructions.2.2. Assembly, screening based on physicochemical properties and selection
of an AMP
The S. s. mutilans transcriptome was assembled de novo, without a
reference genome, using the Trinity method [13]. Sequences that
could not be extended on either end were acquired using TGICL soft-
ware [14]. The resulting sequences (contigs and singletons), referred
to as S. s. mutilans Assembled EST (SmAE) sequences, were translated
into amino acid sequences with ESTScan [15]. These amino acid se-
quences were screened for potential AMPs based on physicochemical
properties of known AMPs using EMBOSS PEPSTATS [16]. AMPs were
then selected based on sequence similarity with known AMPs, deter-
mined using BLASTx. Among the putative AMPs thus obtained, the fol-
lowing AMP was synthesized: scolopendin 2. Peptide synthesis was
performed by Anygen Co. (Gwangju, Korea).2.3. Circular dichroism spectroscopy
Circular dichroism (CD) spectra of the peptides were recorded
using a Jasco J-710 CD spectrophotometer (Jasco, Tokyo, Japan) with a
1-mm path length cell. CD was measured at wavelengths from
195 nm to 240 nm (bandwidth, 1 nm; step resolution, 0.1 nm; speed,
50 nm/min; response time, 0.5 s). CD spectra were recorded for the
peptides in the presence of phosphate-buffered saline (PBS),
50% triﬂuoroethanol (TFE), 50 mM SDS micelles, and 0–5 mM
diphosphocholine (DPC) (pH 7.4) at 20 °C. The spectra were averaged
over three scans [17].2.4. Microbial strains
Enterococcus faecium (ATCC 19434), Staphylococcus aureus (ATCC
25923), E. coli O157 (ATCC 43895), Salmonella typhi (ATCC 19430),
Pseudomonas aeruginosa (ATCC 27853), Candida albicans (ATCC
90028), and Candida parapsilosis (ATCC 22019) were obtained from
the American Type Culture Collection (ATCC) (Manassas, VA, USA).
Trichosporon beigelii (KCTC 7707) and Trichophyton rubrum (KCTC
6345) were obtained from the Korean Collection for Type Cultures
(KCTC). Methicillin-resistant S. aureus and antibiotic-resistant
P. aeruginosa were obtained from a tertiary teaching hospital in Daegu,
South Korea. The isolates were processed by the MicroScan WalkAway
96 system for genus and species identiﬁcation. The susceptibility of re-
sistant strains to antimicrobial agents was tested using MicroScan
Gram positive MIC/combo (PC1A), Gram negative MIC/combo (NC44)
and Gram negative breakpoint combo (NBC39) panels [18].2.5. Antimicrobial activity
The bacterial strains were cultured in Luria-Bertani (LB) broth
(Difco) with aeration at 37 °C and the fungal strains were cultured in
yeast extract–peptone–dextrose (YPD) broth (Difco) with aeration at
28 °C. Optical density was measured with a spectrophotometer
(DU530, Beckman, Fullerton, CA, USA) and cell cultures were adjusted
to obtain standardized populations. Cells in the exponential phase
(2 × 106 cells/mL) were dispensed into wells of microtiter plates
(0.1 mL/well). Minimum inhibitory concentration (MIC) was deter-
mined using two-fold serial dilutions of the test peptides, based on
the Clinical and Laboratory Standards Institute (CLSI) method [19].
The MIC values were determined from three independent tests.
2.6. Hemolytic activity
The hemolytic activity of the peptideswas evaluated by determining
the release of hemoglobin from a 4% suspension of human erythrocytes,
measured at 414 nm with an ELISA reader. Hemolytic levels of 0
and 100% were determined in PBS (35 mM phosphate buffer, 150 mM
NaCl, pH 7.4) andwith 0.1% Triton X-100, respectively. Percent hemoly-
sis was calculated as follows: hemolysis (%) = [(Abs414 nm in the pep-
tide solution− Abs414 nm in PBS) / (Abs414 nm in 0.1% Triton X-100−
Abs414 nm in PBS)] × 100 [20].
2.7. Permeability of microbial cells
E. coli O157 and C. albicans cells in the log phase (2 × 106 cells/mL)
were suspended in PBS and treated with the MICs of the peptides.
After incubation for 4 h at 37 °C and 28 °C, respectively, the cells were
harvested by centrifugation and resuspended in PBS. Subsequently,
the cells were treated with 1 μM SYTOX Green. The cells were analyzed
with a FACSCalibur ﬂow cytometer (Becton Dickinson, San Jose, CA,
USA) [21].
2.8. Membrane depolarization
Log-phase cells of E. coliO157 and C. albicans (2× 106 cells/mL)were
harvested and resuspended in PBS. After incubationwith theMICs of the
peptides for 4 h at 37 °C and 28 °C, respectively, the cellswere again har-
vested by centrifugation and resuspended in PBS. Subsequently, the
cells were treated with 50 μg/mL bis-(1,3-dibutylbarbituric acid)
trimethine oxonol [DiBAC4(3)] (Molecular Probes, Eugene, OR, USA).
Flow cytometric analysis was performed using a FACSCalibur ﬂow
cytometer [22].
E. coli O157 cells were harvested by centrifugation (3500 rpm,
7 min), washed in 5 mM HEPES buffer (pH 7.2) containing
20 mM glucose, and resuspended in buffer (5 mM HEPES buffer,
20 mM glucose, 100 mM KCl, pH 7.2) to an OD600 of 0.05. Harvested
C. albicans cells (2 × 106 cells/mL) were washed with Ca2+- and Mg2+-
free PBS. Changes in the membrane potential were measured using a
membrane-potential-sensitive probe, 3,3′-dipropylthiacarbocyanine io-
dide [DiSC3(5)]. To determine the effect of salt, the cells were treated
with peptide (at theMIC) under various salt conditions (ﬁnal concentra-
tions: 150 mM NaCl and 1 mMMgCl2). Changes in ﬂuorescence due to
the collapse of the cytoplasmic membrane potential were monitored
continuously using a spectroﬂuorophotometer (Shimadzu, RF-5301PC,
Shimadzu, Kyoto, Japan) at an excitation wavelength of 622 nm and an
emission wavelength of 670 nm. The experiment was repeated three
times under each condition to ensure reproducibility [23,24].
2.9. Leakage of potassium
The antimicrobial activity of the peptides was analyzed by measur-
ing the efﬂux of potassium ions from E. coli O157 and C. albicans cells
using an ISE meter (Orion Star A214, Thermo Scientiﬁc, Singapore).
Fig. 1. Alignment of amino acid sequences of scolopendin 2, buforin 2, temporins, and CPF-AM4.
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tide for 4 h at 37 °C and 28 °C, respectively. The incubated cells were
then centrifuged at 12,000 rpm for 5 min to remove cell debris. The po-
tassium ion concentration in the supernatant was expressed as a per-
centage of the total free potassium, which was determined following
sonication of the cells [25,26].
2.10. Calcein leakage from giant unilamellar vesicles
Giant unilamellar vesicles (GUVs) with encapsulated calcein were
prepared using indium tin oxide (ITO)-coated glass slides. The following
lipid mixtures were prepared at a concentration of 3.75 mg/mL in chlo-
roform: phosphatidylethanolamine (PE)/phosphatidylglycerol (PG)
(3:1, w/w) and phosphatidylcholine (PC)/PE/phosphatidylinositol
(PI)/ergosterol (5:4:1:2, w/w/w/w) [27]. PE was L-α-phosphatidyletha-
nolamine from egg yolk, Type III (P7943, Sigma). PG was L-α-
phosphatidyl-DL-glycerol sodium salt from egg yolk lecithin (P8318,
Sigma). PC was L-α-phosphatidylcholine from egg yolk, Type XVI-E
(Sigma) that has fatty acid contents of approximately 33% 16:0 (palmitic),
13% 18:0 (stearic), 31% 18:1 (oleic), and 15% 18:2 (linoleic) (other fatty
acids being minor contributors). PI was L-α-phosphatidylinositol from
Glycinemax (soybean) (P6636, Sigma). Acyl chain compositions of phos-
pholipid used were composed of saturated or unsaturated fatty acid part.
The lipid mixtures (200 μL) were spread onto ITO-coated glass in a spin
coater (Spin coater, ACE-1020 Series) at 500 rpm for 5 min. The lipid-
coated ITO glass was subjected to evaporation under vacuum for 3 h.
Lipid-coated and uncoated glass slides were placed facing each otherFig. 2.Circular dichroism spectra of scolopendin 2 (50 μM) in the presence of PBS, 50% TFE,
50 mM SDS, and 50 mM DPC (pH 7.4).with a 2-mm-thick Teﬂon spacer between them. The chamber was ﬁlled
with buffer (10mMHEPES buffer, pH 7.2, 10 μM. glucose, 1 mM calcein),
and an alternating voltagewith an amplitude of 1.7 V (peak-to-peak, sine
wave) and frequency of 10 Hz was applied to the ITO electrodes using a
sweep function generator (SWEEP FUNCTION GENERATOR 9205C,
Protek) for 2 h. The voltage across the ITO glass was changed to 4 V
(peak-to-peak) at 4 Hz for 10 min. Gel ﬁltration chromatography on a
Sephadex G-50 column was used to remove free calcein from the
calcein-containing GUVs. The GUVs were treated with the peptides and
changes were observed with an inverted ﬂuorescence microscope
(Eclipse Ti-S, Nikon, Japan) [28,29].
2.11. FITC-dextran leakage from large unilamellar vesicles
To prepare large unilamellar vesicles (LUVs) containing ﬂuorescein
isothiocyanate-labeled dextrans (FITC-dextran)with averagemolecular
weights of 4000, 10,000, 20,000, 40,000, and 70,000 (FD 4, FD 10, FD 20,
FD 40, and FD 70), lipid mixtures of the same composition to the GUVs
were evaporated, hydrated in dye buffer solution (10mMTris, 150mM
NaCl, and 0.1 mM EDTA, pH 7.4), and mixed with each FD. The suspen-
sions were subjected to 13 freeze–thaw cycles and extruded through
two stacked polycarbonate ﬁlters (200-nm pores) with a LiposoFast ex-
truder (Avestin Inc., Ottawa, Canada). Gel ﬁltration chromatography on
a Sephadex G-50 column was performed to separate LUVs from free
dye. Dye leakage from the LUVs was monitored by measuring the
intensity of ﬂuorescence at an excitation wavelength of 494 nm
and an emission wavelength of 520 nm using a spectroﬂuoro-
photometer (Shimadzu, RF-5301PC, Shimadzu, Kyoto, Japan), while 1%
Triton X-100 was used to determine 100% dye release. The percentTable 1
The antimicrobial activity of scolopendin 2, BUF(6–21) and melittin.
Microbial strains MIC (μM)
Scolopendin 2 BUF(6–21) Melittin
Gram-positive bacteria
E. faecium ATCC 19434 12.5 25.0 3.1
S. aureus ATCC 25923 25.0 25.0 1.6
MRSA 1 12.5 12.5 3.1
MRSA 2 12.5 25.0 3.1
MRSA 3 12.5 25.0 1.6
Gram-negative bacteria
E. coli O157 ATCC 43895 6.3 6.3 3.1
S. typhi ATCC 19430 12.5 6.3 1.6
P. aeruginosa ATCC 27853 12.5 12.5 3.1
ARPA 1 6.3 6.3 1.6
ARPA 2 12.5 6.3 1.6
ARPA 3 12.5 12.5 3.1
Fungal strains
C. albicans ATCC 90028 6.3 12.5 3.1
C. parapsilosis ATCC 22019 12.5 25.0 3.1
T. beigelii KCTC 7707 6.3 12.5 3.1
T. rubrum KCTC 6345 6.3 12.5 6.3
E. faecium: Enterococcus faecium, S. aureus: Staphylococcus aureus,MRSA:methicillin-resis-
tant Staphylococcus aureus, E. coli: Escherichia coli O157, S. typhi: Salmonella typhi,
ARPA: antibiotics-resistant Pseudomonas aeruginosa, C. albicans: Candida albicans,
C. parapsilosis: Candida parapsilosis, T. beigelii: Trichosporon beigelii, T. rubrum: Trichophyton
rubrum.
Table 2
Human erythrocyte lysis assay against scolopendin 2, BUF(6–21) and melittin.
Peptides Hemolysis (%)
100.0 μM 50.0 μM 25.0 μM 12.5 μM 6.3 μM 3.1 μM 1.6 μM
Scolopendin 2 0 ± 0.2 0 ± 0.3 0 ± 0.5 0 ± 0.4 0 ± 0.4 0 ± 0.3 0 ± 0.8
BUF(6–21) 0 ± 0.4 0 ± 0.2 0 ± 0.1 0 ± 0.3 0 ± 0.5 0 ± 0.7 0 ± 0.6
Melittin 100 ± 3.6 100 ± 2.8 100 ± 7.2 100 ± 6.1 75.3 ± 5.7 42.9 ± 6.7 12.3 ± 4.2
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age (%) = 100 × (F− F0) / (Ft− F0), where F represents the ﬂuores-
cence intensity achieved after addition of the peptides and F0 and Ft
represent the ﬂuorescence intensities without any compound and
with Triton X-100, respectively [30]. The data represent the mean ±
standard deviation of three independent experiments.
3. Results
3.1. Characterization and antimicrobial activity of scolopendin 2
The transcriptome of the centipede S. s. mutilanswas sequenced, and
corresponding peptide sequences were acquired. Following sequential
BLAST analysis of these peptide sequences to determine similarity
with known AMP sequences, a cationic AMP was selected and synthe-
sized. The amino acid sequence of the selected peptide, termed
scolopendin 2, was AGLQFPVGRIGRLLRK. The purity and observed
molecular mass of the synthesized peptide were 99.6% and 1780.4 Da
(calculated mass = 1781.2 Da), respectively. The net charge at physio-
logical pH was +4. Scolopendin 2 has sequence similarity with previ-
ously reported AMPs such as buforin 2, temporins, and CPF-AM4 [5,31,
32]. The highest homologywas observedwith buforin 2 (66.7%),where-
as the similaritywith temporin-1ARa, temporin-AJ8, temporin-CPb, and
CPF-AM4 was 42.7%, 45.0%, 42.1%, and 42.1%, respectively (Fig. 1). In
particular, scolopendin 2 is very similar to buforin 2, and is almost iden-
tical to residues 6–21 in that peptide, BUF(6–21). The peptides has the
same length and differ only at two positions, I15V and G16H. The anti-
microbial activity of BUF(6–21) was reported but the mechanism was
not yet studied [31]. Based on these sequence similarities with potent
antimicrobial peptides, we hypothesized that scolopendin 2 also pos-
sesses antimicrobial properties. To investigate alterations of the second-
ary structure of the peptide, CD spectroscopywas conducted in PBSwith
or without TFE, SDS, and DPC. As shown in Fig. 2, the results indicate
that the peptide has an α-helical properties in membrane-like condi-
tions but a random coil pattern in PBS.
To investigate the antimicrobial effect of scolopendin 2, a MIC test
was performed against several pathogenic and antibiotic-resistantFig. 3.Membrane permeabilization of (A) E. coli O157 and (B) C. albicans, detected by SYTOX G
MIC. (a) Control, (b) scolopendin 2, (c) BUF(6–21), (d) melittin.strains of bacteria and fungi. Melittin, having broad-spectrum antimi-
crobial activity [33], and BUF(6–21), having high similarity [31], was
used as control peptides. As shown in Table 1, scolopendin 2 had antimi-
crobial activity, with MIC values in the range of 6.3 to 25.0 μM. BUF(6-
21) showed a similar antimicrobial activity, with a slightly lower activ-
ity than scolopendin 2, but always within one dilution factor. Melittin,
with MIC values in the range of 3.1 to 6.3 μM, was more potent than
scolopendin 2. However, scolopendin 2 and BUF(6–21) showed no he-
molytic activity towards human erythrocytes, at any concentration
(Table 2). These results indicate that scolopendin 2 has potential as an
AMP with no hemolytic effect.
3.2. Cell permeabilization and depolarization of the membrane
AMPs have many mechanism(s) to kill microbes: (1) inhibition of
cell wall synthesis, (2) disruption of the cytoplasmic membrane,
(3) binding to DNA and (4) inhibition of protein synthesis. Among
these mechanisms, disruption of the cell membrane is the most com-
mon [4]. Therefore, the effect of scolopendin 2 on bacteria and
fungi was analyzed by monitoring the uptake of SYTOX Green, a
membrane-impermeable DNA-binding molecule [34]. When treated
with scolopendin 2, BUF(6–21) and melittin, 27.2%, 2.2% and 81.7% of
the E. coliO157 cells and 33.1%, 3.6% and 76.2% of the C. albicans cells ex-
hibited an increase in ﬂuorescence (Fig. 3). Cells treated scolopendin 2
and melittin indicated a signiﬁcant increase in ﬂuorescence intensity.
These results show that the bacterial and fungal cell membranes were
permeabilized by the peptides.
The ability of scolopendin 2 to disrupt bacterial and fungal mem-
brane potentials was investigated using DiBAC4(3), which binds to the
cytoplasmic membrane of cells and allows estimation of themembrane
potential [24]. Compared with untreated cells, 14.9%, 1.4% and 55.0% of
E. coliO157 cells and 21.2%, 6.7% and 78.2% of C. albicans cells exposed to
scolopendin 2, BUF(6–21) and melittin, respectively, showed an in-
crease in ﬂuorescence intensity (Fig. 4). Peptide-treated cells showed
an accumulation of DiBAC4(3), indicating that scolopendin 2 caused de-
polarization of the membrane. The results of scolopendin 2 implied a
membrane active mechanism of this peptide, whereas for BUF(6–21)reen ﬂuorescence. The cells were treated with scolopendin 2, BUF(6–21) or melittin at the
Fig. 5.Depolarization of E. coli O157 (A–B) and C. albicans (C–D) cell membranes were detected using DiSC3(5). DiSC3(5) was added at t = 20 s. After internalization of the probe, at
t = 150 s, the MIC of scolopendin 2 or melittin was added and changes in ﬂuorescence were monitored (excitation, 622 nm; emission, 670 nm). (A, C) Peptides with 150 mM NaCl;
(B, D) peptides with 1 mM MgCl2.
Fig. 4. Flow cytometric analysis of DiBAC
4
(3) staining after incubation of (A) E. coli O157 and (B) C. albicanswith the MIC of the peptides. (a) Control, (b) scolopendin 2, (c) BUF(6–21),
(d) melittin.
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Fig. 7. Fluorescence from calcein-containing GUVs in the presence of the peptides at 0, 10,
20, 30, and 40 s. (A, D) Photobleaching, (B, E) scolopendin 2, (C, F)melittin. The bar repre-
sents 10 μm.
Fig. 6. Potassium leakage after incubation of (A) E. coli O157 and (B) C. albicans cells with the MIC of scolopendin 2 or melittin. The error bars represent the standard deviation.
639H. Lee et al. / Biochimica et Biophysica Acta 1848 (2015) 634–642the mechanism was not clearly identiﬁed. Accordingly, only melittin
was used as a membrane-active control peptide in subsequent
experiments.
When DiSC3(5), a potential-dependent distributional ﬂuorescent
dye [25], was added to cell suspensions (for 20 s), it was taken up and
concentrated in themembrane, resulting in a steady baseline of ﬂuores-
cence intensity. After quenching of the ﬂuorescence of DiSC3(5), treat-
ment with scolopendin 2 (for 150 s) led to a further increase in
ﬂuorescence intensity, albeit less than that observed with melittin.
Moreover, the peptide activity decreased in the presence of 150 mM
NaCl or 1 mM MgCl2 (Fig. 5). These results show that scolopendin 2
can disrupt the cytoplasmic membrane and that its activity is inhibited
by salt-dependent manner.
3.3. Release of intracellular potassium
To further investigate membrane damage, peptide-induced potassi-
um release wasmeasured using a potassium-sensitive electrode. Potas-
sium efﬂux induced by scolopendin 2 was less than that induced by
melittin. Potassium ion leakage from untreated E. coli O157 and
C. albicans cells was 14.3% and 20.9%, respectively, while leakage from
E. coli O157 and C. albicans cells treated with scolopendin 2 was 28.6%
and 53.5%, respectively. In comparison, melittin-treated E. coli O157
and C. albicans cells leaked 42.9% and 88.4% of their potassium ions, re-
spectively (Fig. 6). These results suggest that scolopendin 2 induces in-
tracellular leakage.
3.4. Leakage of calcein from model membranes
To further investigate the membrane-active mechanism of
scolopendin 2, artiﬁcial membranes were prepared and the extent of
membrane damage induced by the peptides was measured. A self-
quenching concentration of calcein was encapsulated in GUVs com-
posed of PE/PG (3:1, w/w), which mimicked the inner membrane of
E. coli, or PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w), which mimicked
the outer cell membrane of C. albicans [27]. Using inverted microscopy,
we observed the changes in ﬂuorescence from the two kinds of GUVs
after the addition of peptide. Treatment with scolopendin 2 or melittin
remarkably diminished the ﬂuorescence of both GUVs. No changes
were observed in the ﬂuorescence intensity of control GUVs (Fig. 7).
These results show that scolopendin 2 induced calcein leakage from
GUVs, indicating that the structure of the liposomes was substantially
disrupted.3.5. FITC-dextran release by pore formation
To evaluate the size of the pores created by scolopendin 2 in the
E. coliO157 and C. albicansmembranes, the efﬂux of variably sized ﬂuo-
rescent molecules through the model membranes was observed. After
the addition of scolopendin 2 to the model membranes, efﬂux of FD 4
(Stokes–Einstein radius = 1.4 nm), FD 10 (Stokes–Einstein radius =
2.3 nm), FD 20 (Stokes–Einstein radius = 3.3 nm) [35], and FD 40
(Stokes–Einstein radius= 4.8 nm) [36] from the liposomes was detect-
ed. However, no efﬂux from liposomes with encapsulated FD 70
(Stokes–Einstein radius = 5.0 nm) was observed. These results suggest
that the size of the pores induced by scolopendin 2was between 4.8 nm
and 5.0 nm (Fig. 8).
Fig. 8. FITC-dextran leakage from PE/PG (3:1, w/w) and PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w) LUVs induced by the scolopendin 2 andmelittin. (A) E. coliO157, (B) C. albicans. The leak-
age of FD70 from LUVS was not shown. The error bars represent the standard deviation of three independent experiments, each performed three times.
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AMPs from various organisms have been reported. Their amino acid
composition, structure, net charge, and size are perceived to be signiﬁ-
cant properties that allow them to bind to or insert themselves into mi-
crobial pathogens, thus bringing about antimicrobial action through
various mechanisms [5]. In a previous study, we identiﬁed scolopendin
1, an AMP from S. s. mutilans, by the same methods used in the present
study; this AMP exerts its antifungal effect by triggering the apoptotic
pathway [12]. In contrast, thepeptide identiﬁed in thiswork, designated
scolopendin 2, affects cell membranes. Scolopendin 2was found to have
sequence similarity with known antimicrobial peptides, including
buforin 2, which targets nucleic acids without causing cell lysis [31,
37]; temporins, which are known to disrupt the cytoplasmicmembrane
[5]; and CPF-AM4, from the caerulein-precursor fragment peptide
family, which also shows antibacterial activity [32]. Before exploring
the antimicrobial potential of scolopendin 2,we examined its secondary
structure. CD spectroscopy showed that scolopendin 2 has an α-helical
properties; such properties often have critical roles for microorganisms.
Generally, AMPs are classiﬁed into ﬁve groups based on their struc-
ture: peptideswithα-helical structure; cysteine-rich peptides; peptides
with β-sheet structure; peptides rich in histidine, arginine, and proline;
and peptides with uncommon or modiﬁed amino acids. Among these
classes, AMPs with α-helical properties are the most common [18].
Based on its structure, scolopendin 2 was considered a potential AMP.
Therefore, we tested its antimicrobial activity and found that it was ef-
fective against morbiﬁc Gram-positive and Gram-negative bacteria, in-
cluding antibiotic-resistant bacteria, and fungi. Among the susceptible
strains, E. coli O157 and C. albicans were selected as model pathogenic
microorganisms for further experiments [38,39]. Although scolopendin
2, BUF(6–21) hadweaker antimicrobial activity thanmelittin, it showed
no hemolytic effect on human erythrocytes. BUF(6–21) is a synethetic
analog of buforin 2 with the same length as scolopendin 2 and only
two differences in the amino acid sequence, I15V and G16H. Its antimi-
crobial activity was reported previously but the mechanism was so far
not studied [31].
Potential modes of action of AMPs include fatal depolarization of the
normally polarized membrane, formation of physical pores, scrambling
of the usual distribution of lipids between the leaﬂets of the bilayer, and
damage to critical intracellular targets. Cell death is induced by leakage
of cellular contents and disturbance of membrane functions [37]. We
considered it likely that a cationic peptide would damage plasmamem-
branes. Therefore, to identify themode(s) of action of scolopendin 2,weobserved the effect of this peptide on bacterial and fungal plasmamem-
branes. When cells are incubated with SYTOX Green, a ﬂuorescent dye
that intercalates with DNA but cannot cross intact cell membranes, an
increase in ﬂuorescence indicates cell death via membrane perme-
abilization [21] and breach of the plasma membrane [34]. Scolopendin
2 affected microbial cells by damaging their membranes and thus en-
hancing membrane permeability.
An increase in plasma membrane permeability can disrupt intracel-
lular electrochemical gradients [40]. Using DiBAC4(3) and DiSC3(5), in-
dicators ofmembrane potential, we showed that themembranes of cells
exposed to scolopendin 2 were depolarized. Antimicrobial mechanisms
that target the intracellular matrix cause little or no depolarization of
membranes [20]. Therefore, we anticipated that the mechanism of
scolopendin 2 did not involve inhibition of proteins or nucleic acids.
BUF(6–21) was showed little depolarization andmembrane permeabil-
ity and it seems that the mechanism is not membrane related. There-
fore, we used melittin as a positive control for comparing activity of
the mode of action. Furthermore, membrane depolarization was re-
duced under physiological conditions in the presence of salt. As report-
ed previously, a high sodium chloride concentration inhibits the
antimicrobial activity of AMPs, and other salts, such as those with diva-
lent ions, are even more inhibitory. Disruption of the interaction be-
tween the negatively charged membrane and the positively charged
peptide is considered the cause of inhibition and is dependent on ionic
strength [41]. The fact that scolopendin 2 was less susceptible to salt in-
hibition than melittin, which has a higher net charge, is a sign that this
hypothesis is correct.
The potassium ion gradient is an important determinant of cell
growth and survival because of its role in regulating cytoplasmic pH
and cell structure [42]; therefore, a loss of cytoplasmic potassium
would lead to cell death in bacteria and fungi [43,44]. Leakage of potas-
sium ions has beenused to determinemembrane lytic events in bacteria
and yeast because the internal ionic environment in prokaryotic and eu-
karyotic cells is usually potassium-rich [45]. The loss of the potassium
gradient across the cell membrane, indicated by membrane depolariza-
tion, is an outcome ofmembrane damage and increasedmembrane per-
meability. The results of our study indicate that scolopendin 2 affects
membrane integrity, leading to altered potassium efﬂux and subse-
quent depolarization of microbial membranes.
Positively charged peptides accumulate on anionic microbial cell
surfaces containing acidic polymers and subsequently contact the cyto-
plasmic membrane [46]. Membrane permeabilization and depolariza-
tion by AMPs causes disruption of the bilayer, inducing the formation
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understand the membrane-active mechanism of scolopendin 2, we
used GUVs containing calcein. These GUVs mimicked the phospholipid
composition of E. coli and C. albicans cell membranes. Morphological
changes in artiﬁcial membranes allow the study of structural and phys-
ical changes during interactionswith antimicrobial agents such as AMPs
[48,49]. Changes in ﬂuorescence are attributed to structural perturba-
tion of the model membrane after interaction with these agents [11].
We observed that the ﬂuorescence from liposomes gradually decreased,
indicating that the ﬂuorescent probes were escaping through pores in
the liposomes. The liposomes did not shrink or collapse into micelles.
These results indicate that the membrane-active mechanism of
scolopendin 2 lies in pore formation within bacterial and fungal
membranes.
To determine the size of the pores induced by scolopendin 2, we ob-
served the efﬂux of FITC-dextrans, water-soluble ﬂuorescent molecules
with varying sizes, from LUVs. The pores induced by the peptide facili-
tated the efﬂux of FD 40 but not FD 70, indicating that the diameter of
the pores in both types of liposomes used in this experiment was at
least 4.8 nm but less than 5.0 nm. Melittin induces toroidal pores with
a diameter of 3.0–5.0 nm [36] and allows passage of molecules of up
to tens of kilodaltons at the micromolar scale [50]. Likewise, pores in-
duced by scolopendin 2 seemed to permit transmission of small mole-
cules or monatomic ions such as potassium. Migration of larger
molecules such as glucose is anticipated.
In conclusion, scolopendin 2 was identiﬁed as a cationic AMP from
S. s. mutilans that exhibits antimicrobial activities without causing he-
molysis of human erythrocytes. Scolopendin 2 has a different mecha-
nism of action than scolopendin 1, a previously identiﬁed AMP from
the same centipede. Its membrane-active mechanism leads to the for-
mation of pores in microbial plasma membranes, subsequent leakage
of cytoplasmic matrix components, and consequent membrane depo-
larization, ultimately resulting in microbial cell death. These ﬁndings
suggest that scolopendin 2 is a valuable source of AMP for human
health and could be useful in area of food, cosmetic or pharmaceutical
applications.
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